Cure My Disease

Don't miss your cure!

 Log in / Sign up

Red wine compound may supercharge strength training for seniors

NCT ID NCT06585865

Disease control Sponsor: Texas Tech University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study investigates whether taking resveratrol—a compound found in red wine—can improve the muscle, blood vessel, and brain benefits of strength training in adults aged 60 and older. Participants will take resveratrol or a placebo while following a supervised strength training program for 12 weeks. The goal is to see if resveratrol enhances muscle strength, endurance, and overall health by affecting tiny particles called extracellular vesicles that help cells communicate.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
resveratrol
What this could lead to
If it works, this could point toward a simple supplement to enhance the muscle, blood vessel, and brain benefits of strength training in older adults.
What could go wrong
This is an early-stage, small study (36 participants). The results may not apply to everyone, and resveratrol may not provide additional benefits beyond exercise alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 60+ * Minimally active (less than 1 hour of structured exercise/week other than walking) * No resistance training for the previous 6 months * Not currently taking resveratrol supplements * Stable medication, supplement, dietary, and physical activity regimens for the previous 3 months and no plans to change throughout the study period * Body mass at least 110 lbs Exclusion Criteria: * Medical complications that could increase risk during exercise (e.g., cardiovascular disease, uncontrolled hypertension, type 1 or 2 diabetes, orthopedic contraindication to exercise, kidney disease, etc.) * Cannabis or nicotine use * Consume more than 7 alcohol-containing beverages per week

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anabolic resistance are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anabolic resistance Sarcopenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Kinesiology & Sport Management, Texas Tech University

    RECRUITING

    Lubbock, Texas, 79409, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.